LABU vs. IBIC
LABU (Direxion Daily S&P Biotech Bull 3x Shares) and IBIC (iShares iBonds Oct 2026 Term TIPS ETF) are both exchange-traded funds - LABU is a Leveraged Equities fund tracking the S&P Biotechnology Select Industry Index (300%), while IBIC is a Inflation-Protected Bonds fund tracking the ICE 2026 Maturity US Inflation-Linked Treasury Index. Both are passively managed. Over the past year, LABU returned 324.35% vs 4.42% for IBIC. At a correlation of -0.00, they often move in opposite directions. LABU charges 1.12%/yr vs 0.10%/yr for IBIC.
Performance
LABU vs. IBIC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LABU achieves a 47.57% return, which is significantly higher than IBIC's 2.43% return.
LABU
- 1D
- 2.26%
- 1M
- 34.26%
- YTD
- 47.57%
- 6M
- 36.98%
- 1Y
- 324.35%
- 3Y*
- 23.36%
- 5Y*
- -31.01%
- 10Y*
- -7.18%
IBIC
- 1D
- 0.04%
- 1M
- 0.12%
- YTD
- 2.43%
- 6M
- 2.57%
- 1Y
- 4.42%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
LABU vs. IBIC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
LABU Direxion Daily S&P Biotech Bull 3x Shares | 47.57% | 79.17% | -26.02% | 30.09% |
IBIC iShares iBonds Oct 2026 Term TIPS ETF | 2.43% | 4.96% | 5.25% | 2.17% |
Correlation
The correlation between LABU and IBIC is -0.18, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.18 |
Correlation (All Time) Calculated using the full available price history since Sep 15, 2023 | -0.00 |
The correlation between LABU and IBIC shifts across timeframes, from -0.18 (1 year) to -0.00 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LABU vs. IBIC — Risk / Return Rank
LABU
IBIC
LABU vs. IBIC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bull 3x Shares (LABU) and iShares iBonds Oct 2026 Term TIPS ETF (IBIC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| LABU | IBIC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.84 | ||
| Sortino ratioReturn per unit of downside risk | -5.31 | ||
| Omega ratioGain probability vs. loss probability | 1.44 | 2.22 | -0.79 |
| Calmar ratioReturn relative to maximum drawdown | 10.64 | 16.56 | -5.92 |
| Martin ratioReturn relative to average drawdown | 29.90 | 58.67 | -28.78 |
Loading charts...
Drawdowns
LABU vs. IBIC - Drawdown Comparison
The maximum LABU drawdown since its inception was -99.18%, which is greater than IBIC's maximum drawdown of -0.90%. Use the drawdown chart below to compare losses from any high point for LABU and IBIC.
Loading charts...
Drawdown Indicators
| LABU | IBIC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.18% | -0.90% | -98.28% |
Max Drawdown (1Y)Largest decline over 1 year | -30.70% | -0.27% | -30.43% |
Max Drawdown (3Y)Largest decline over 3 years | -78.30% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -97.59% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -98.96% | — | — |
Current DrawdownCurrent decline from peak | -94.80% | -0.08% | -94.72% |
Average DrawdownAverage peak-to-trough decline | -81.72% | -0.10% | -81.62% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.91% | 0.08% | +10.83% |
Volatility
LABU vs. IBIC - Volatility Comparison
Direxion Daily S&P Biotech Bull 3x Shares (LABU) has a higher volatility of 29.76% compared to iShares iBonds Oct 2026 Term TIPS ETF (IBIC) at 0.17%. This indicates that LABU's price experiences larger fluctuations and is considered to be riskier than IBIC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LABU | IBIC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 29.76% | 0.17% | +29.59% |
Volatility (6M)Calculated over the trailing 6-month period | 63.07% | 0.67% | +62.40% |
Volatility (1Y)Calculated over the trailing 1-year period | 78.78% | 0.89% | +77.89% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 95.94% | 1.56% | +94.38% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 95.44% | 1.56% | +93.88% |
LABU vs. IBIC - Expense Ratio Comparison
LABU has a 1.12% expense ratio, which is higher than IBIC's 0.10% expense ratio.
Dividends
LABU vs. IBIC - Dividend Comparison
LABU's dividend yield for the trailing twelve months is around 0.52%, less than IBIC's 3.58% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
IBIC iShares iBonds Oct 2026 Term TIPS ETF | 3.58% | 4.43% | 4.65% | 0.83% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LABU Direxion Daily S&P Biotech Bull 3x Shares | 0.52% | 0.84% | 0.35% | 0.35% | 0.00% | 0.00% | 0.00% | 0.28% | 0.64% | 0.17% |
Frequently Asked Questions
LABU and IBIC have a correlation of -0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LABU has higher volatility (29.76%) compared to IBIC (0.17%). In terms of maximum drawdown, LABU dropped -99.18% vs IBIC's -0.90%.
On 1-year performance, LABU leads with 324.35% vs 4.42% for IBIC. On fees, IBIC is cheaper at 0.10% per year. On volatility, IBIC has been the lower-risk option at 0.17%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, LABU has performed better with a 324.35% return vs 4.42%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IBIC is cheaper with a 0.10% expense ratio, compared with 1.12% for LABU.
IBIC has the higher dividend yield at 3.58%, compared with 0.52% for LABU.
LABU is categorized as Leveraged Equities, while IBIC is Inflation-Protected Bonds. LABU tracks S&P Biotechnology Select Industry Index (300%), while IBIC tracks ICE 2026 Maturity US Inflation-Linked Treasury Index. They also come from different issuers: Direxion and iShares. Their fees differ too: 1.12% for LABU and 0.10% for IBIC.
IBIC currently has the higher Sharpe Ratio (4.99 vs 4.15), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LABU and IBIC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer